Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Duchateau

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Current Gene Therapy|February 20, 2007
Meganucleases and DNA double-strand break-induced recombination: perspectives for gene therapyFrédéric Pâques, Philippe Duchateau
Expert Opinion on Biological Therapy|August 20, 2009
Targeted approaches for gene therapy and the emergence of engineered meganucleasesRoman Galetto, Philippe Duchateau, Frédéric Pâques
Current Gene Therapy|July 30, 2013
Genome engineering with TAL-effector nucleases and alternative modular nuclease technologiesAndrew M Scharenberg, Philippe Duchateau, Julianne Smith
Frontiers in Immunology|May 30, 2023
Stromal depletion by TALEN-edited universal hypoimmunogenic FAP-CAR T cells enables infiltration and anti-tumor cytotoxicity of tumor antigen-targeted CAR-T immunotherapyShipra Das, Julien Valton, Philippe Duchateau, et al.
The Journal of Biological Chemistry|February 27, 2019
Granulocyte-macrophage colony-stimulating factor inactivation in CAR T-cells prevents monocyte-dependent release of key cytokine release syndrome mediatorsMohit Sachdeva, Philippe Duchateau, Stéphane Depil, et al.
Nucleic Acids Research|April 13, 2011
Context dependence between subdomains in the DNA binding interface of the I-CreI homing endonucleaseSylvestre Grizot, Aymeric Duclert, Séverine Thomas, et al.
BMC Bioinformatics|June 18, 2014
Efficient design of meganucleases using a machine learning approachMikhail Zaslavskiy, Claudia Bertonati, Philippe Duchateau, et al.
Current Gene Therapy|December 25, 2010
Meganucleases and other tools for targeted genome engineering: perspectives and challenges for gene therapyGeorge Silva, Laurent Poirot, Roman Galetto, et al.
Frontiers in Bioengineering and Biotechnology|July 17, 2020
Straightforward Generation of Ultrapure Off-the-Shelf Allogeneic CAR-T CellsAlexandre Juillerat, Diane Tkach, Ming Yang, et al.
Scientific Reports|January 12, 2016
Design of chimeric antigen receptors with integrated controllable transient functionsAlexandre Juillerat, Alan Marechal, Jean-Marie Filhol, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Current Gene Therapy|February 20, 2007
Meganucleases and DNA double-strand break-induced recombination: perspectives for gene therapyFrédéric Pâques, Philippe Duchateau
Expert Opinion on Biological Therapy|August 20, 2009
Targeted approaches for gene therapy and the emergence of engineered meganucleasesRoman Galetto, Philippe Duchateau, Frédéric Pâques
Current Gene Therapy|July 30, 2013
Genome engineering with TAL-effector nucleases and alternative modular nuclease technologiesAndrew M Scharenberg, Philippe Duchateau, Julianne Smith
Frontiers in Immunology|May 30, 2023
Stromal depletion by TALEN-edited universal hypoimmunogenic FAP-CAR T cells enables infiltration and anti-tumor cytotoxicity of tumor antigen-targeted CAR-T immunotherapyShipra Das, Julien Valton, Philippe Duchateau, et al.
The Journal of Biological Chemistry|February 27, 2019
Granulocyte-macrophage colony-stimulating factor inactivation in CAR T-cells prevents monocyte-dependent release of key cytokine release syndrome mediatorsMohit Sachdeva, Philippe Duchateau, Stéphane Depil, et al.
Nucleic Acids Research|April 13, 2011
Context dependence between subdomains in the DNA binding interface of the I-CreI homing endonucleaseSylvestre Grizot, Aymeric Duclert, Séverine Thomas, et al.
BMC Bioinformatics|June 18, 2014
Efficient design of meganucleases using a machine learning approachMikhail Zaslavskiy, Claudia Bertonati, Philippe Duchateau, et al.
Current Gene Therapy|December 25, 2010
Meganucleases and other tools for targeted genome engineering: perspectives and challenges for gene therapyGeorge Silva, Laurent Poirot, Roman Galetto, et al.
Frontiers in Bioengineering and Biotechnology|July 17, 2020
Straightforward Generation of Ultrapure Off-the-Shelf Allogeneic CAR-T CellsAlexandre Juillerat, Diane Tkach, Ming Yang, et al.
Scientific Reports|January 12, 2016
Design of chimeric antigen receptors with integrated controllable transient functionsAlexandre Juillerat, Alan Marechal, Jean-Marie Filhol, et al.
Pageof 6